Associate Director, Chemistry @ (August 2021 - January 2024)
Senior Principal investigator @ (June 2021 - August 2021)
Principal Research Scientist @ (May 2018 - August 2021)
Principal Scientist @ Phelix Therapeutics (November 2014 - May 2018)
Senior Research Scientist @ Phelix Therapeutics (April 2014 - May 2018)
Senior Scientist @ Phelix Therapeutics (April 2014 - January 2017)
Postdoctoral Fellow, Chemical Biology @ (June 2011 - February 2014)
PhD @ University of Mississippi (January 2005 - July 2011)
Research Associate @ (January 2003 - January 2004)
Research Chemist @ (June 2002 - July 2003)
Swapnil Kulkarni Education
University of Mississippi
PhD (Medicinal Chemistry)
2006-2010
University of Mumbai
Masters in Pharmaceutical Sciences (Pharmaceutical Chemistry)
2000-2002
University of Rhode Island
Swapnil Kulkarni Skills
Bioconjugate Chemistry
Biotechnology
Characterization
Chemical Biology
Drug Design
Drug Discovery
HPLC
IR
Mass Spectrometry
Medicinal Chemistry
Molecular Modeling
NMR
Oligonucleotides
Organic Chemistry
Organic Synthesis
Peptide Synthesis
Peptides
Project Planning
Protein Chemistry
Purification
Science
Studies in enzymatic resolution
Technology Transfer
Strategic Planning
Biochemistry
Swapnil Kulkarni Summary
Swapnil Kulkarni, based in Philadelphia, PA, US, is currently a Director, Bioconjugation at Aro Biotherapeutics. Swapnil Kulkarni brings experience from previous roles at Aro Biotherapeutics and Phelix Therapeutics. Swapnil Kulkarni holds a 2006 - 2010 PhD in Medicinal Chemistry @ University of Mississippi. With a robust skill set that includes Bioconjugate Chemistry, Biotechnology, Characterization, Chemical Biology, Drug Design and more. Swapnil Kulkarni has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Swapnil Kulkarni?
Find contact details for 700 million professionals.